Thursday, 8 August 2024

Edge of Your Seat: After 765% (Approx) Moves Our Next One is Coming Tonight at 8:00 PM EST or 9:30 AM EST Tomorrow Morning

The Market Crux Streak Continues: After 765% (Approx) Moves Our Next Profile is Coming Tonight at 8:00 PM EST or 9:30 AM EST Tomorrow Morning!


With Our Current Streak, There’s No Doubt You’ll be at the

 Edge of Your Seat For This One!


Take 2 Minutes Now to Connect with Us on all of Our No-Cost Platforms!


(See instructions below)








August 8, 2024



Dear Reader,






Following our profile in the Biotechnology sector, which made an approximate 43% move overnight after closing at $.9665 yesterday and reaching $1.39 today, it's time to get ready for our next exciting profile. 


We will be announcing our next profile tonight around 8:00 PM EST or by 9:30 AM EST tomorrow morning. 


With our current streak, there’s no doubt you’ll be at the edge of your seat for this one.


Here are the highlights of our recent profiles:


Starting with Today’s  Biotech Sector Profile on 8/8/2024

Overnight Move: Approximately 43%


Uranium Exploration Profile From 8/7/2024

Overnight Move: Approximately 51%


Biopharmaceutical Profile From 8/4 - 8/5/2024

Pre-Market Move: Approximately $0.70 to $0.967

Approximate Move: 38%, *257%


*Followed by Subsidiary Merger News

Subsidiary Share price moved from approximately $12.94 to $46.20

Intraday Move: *Approximately 257%


International Wellness Profile From 8/2/2024

Premarket Move: Approximately 42%


Critical Minerals Profile From 7/31/2024

Overnight Move: Approximately 53%


Health Tech Profile From 7/25/2024

Pre-Market Move: Approximately 93%

Followed by a Continued 7-Day Move: Approximately 188%


Now it's time to get ready for our brand new profile announcement coming tonight at 8:00 PM EST or tomorrow morning by 9:30 AM EST!


Upcoming Profile Poised for Potential Breakout: RSI Indicators Mirror Previous Health Tech Profile’s Approximate 188% Move in 7 Days.


  • 20.76% (9-day)
  • 23.27% (14-day)
  • 24.79% (20-day)
  • 30.31% (50-day)


Not to mention it’s stacked with several potential catalysts like:


Innovative Solutions: This company is dedicated to developing groundbreaking treatments for challenging neurodegenerative and metabolic disorders.


World-Class Pipeline: With a robust pipeline targeting multi-bln dollar markets, their research addresses unmet medical needs, backed by decades of dedicated effort.


Diversified Portfolio: Boasting a diversified product portfolio, their first product launch is set for 2024, positioning them to tackle a range of disorders with novel therapeutic solutions.


Strong Intellectual Property: A strong intellectual property portfolio underpins their competitive edge and secures pioneering advancements in the biopharmaceutical sector.


Recent Developments: The submission of clinical trial protocols highlights their commitment to advancing the pipeline and bringing new therapeutic solutions to market.


Analyst Coverage: Current target suggests significant growth potential for this little-known company.


Don't miss out on this —the time to get ready is now!


Our brand new profile announcement is coming tonight at 8:00 PM EST or tomorrow morning by 9:30 AM EST!


In the meantime,  I’m urging you to connect with us on all of our no-cost platforms so you can receive our reports up to 10X faster than email alone.

If you haven't already, please take a moment to set up these platforms now: 


  • SMS: To make sure you’re signed up for our no-cost SMS Alerts, which are up to 10X faster than email, click here.


  • Telegram Channel: Click now to join our no-cost Telegram Channel for real-time updates.


  • WhatsApp: Or if you prefer WhatsApp, click here to join our real-time Market Chatter.


All three of these should take less than 3 minutes to connect but give you a massive advantage in the market. 


But please make sure you set up the SMS, Telegram, and WhatsApp before our next profile reaches you. It’s coming tonight around 8:00 PM EST or by 9:30 AM EST tomorrow morning.

Sincerely,


Gary Silver

Managing Editor,

MarketCrux

MarketCrux (MarketCrux . com) is owned by Headline Media LLC, a limited liability company. Disclosure: I am not a lice.nsed finan.cial adviser. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. MarketCrux full disclosure is to be read and fully understood before using MarketCrux website, or joining MarketCrux's email or text list. By viewing MarketCrux website and/or reading MarketCrux email or text newsletter you are agreeing to MarketCrux full disclosure which can be read at marketcrux.com/disclaimer

No comments:

Post a Comment

Get Ready – This New Income Strategy Is Shocking

There's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don't even pay dividends....